|
|
Enron Mail |
If you are reading this message in plaintext or if you have an AOL address =
you must click on this link: http://listserv.otcjournal.com/otcjournal/2002= 0201-1.html and wait for a web page to automatically open up to properly r= ead this newsletter.=20 [IMAGE]=09=09[IMAGE][IMAGE]=09 [IMAGE]=09 [IMAGE] February 1, 2002 [IMAGE] [IMAGE] Volume V, Issue 9 [IMAGE] = Email : info@otcjournal.com URL : http://www.otcjournal.com To OTC Jou= rnal Members: [IMAGE] For OTC Journal Members There Will Be Two SuperB= owls This Sunday the St. Louis Rams will square off against the New Engla= nd Patriots in the most watched television event of the year. The Superbowl= is the single most hyped sporting event, and hopefully this year it will b= e a good game. Hundreds of millions of viewers world wide will have their t= elevisions tuned in to this event. The St. Louis Rams are favored by two = touchdowns, and most odds makers give the Patriots no chance. The SuperBowl= has a well deserved reputation for being a blowout, with the outcome decid= ed by the end of the first half. It's like the Presidential election. The m= edia decides the outcome with only about 10% of the score being counted. Ho= pefully this year's SuperBowl will prove as close and entertaining as the l= ast Presidential Election. Maybe the Supreme Court will have to decide the = winner. SuperBowl fans know the commercials can be the most exciting part= of the telecast. Advertisers go all out in a creative competition as they = have the opportunity to get their message to largest imaginable audience. = Fans of the OTC Journal will have the opportunity to watch one SuperBowl t= his weekend, and play in one next week. As we continue to remind you, our n= ext profile will come out toward the end of next week, and we believe this = stock will be the SuperBowl of small cap stocks for our members. The stoc= k will begin trading sometime between Wednesday and Friday, and check our h= ome page frequently for an update. As soon as the stock opens for trading w= e will hit the send button on the mail server. It will take about six hours= for the newsletter to deploy, and as always there can be technology delays= on the Internet. However, the banner on our home page will update you au= tomatically, and you will be able to simply click on it to read the profile= when the stock opens for trading. Hopefully we will be able to provide a m= ore precise time frame in an edition early next week. [IMAGE] Small And= MicroCap Stocks Avoid Wall Street Carnage This Week [IMAGE] The latest GD= P and Unemployment figures came out stronger than expected this week, leadi= ng investors to believe the end of the recession is right on schedule. Ho= wever, this good news was overshadowed by scandal related selling early in = the week. The Dow and Nasdaq were clobbered early in the week, slipping bel= ow 9700 and 1900 respectively. The thinking on Wall Street was dominated = by the belief that the Enron accounting scandal was just the tip of the ice= berg, and other company's financial statements would come under increased s= crutiny. Behemoth multi national Tyco (NYSE: TYC) was annihilated early = in the week on fears they have been cooking the books. It was disclosed one= of their directors received a $20 million payment for arranging an acquisi= tion. Many feel this was a blatant conflict of interest. Telecommunicatio= ns giant Global Crossing (NYSE: GX) filed bankruptcy this week. Chairman Ga= ry Winnick has taken $600 million off the table personally in the last five= years. Quite a reward for failure. Anadarko Petroleum (NYSE: APC) announ= ced a $1.7 billion non cash charge to earnings in order to correct previous= accounting issues. The stock fell nearly 8% on the news. ImClone Systems= (NASDAQ: IMCL) is being investigated by the SEC and the Justice Department= . The company is accused of misleading investors on the highly touted colon= cancer drug Erbitux. CEO Samuel Waksal told investors on a conference call= that he was "stunned'' at the FDA's decision to refuse the cancer drug app= lication for Erbitux. However a copy of the FDA's rejection letter was obta= ined by The Cancer Letter. It suggests Waksal and his brother Harlan knew, = or should have known, that the FDA had serious concerns about the way the c= ompany conducted a key clinical trial. Harlan Waksal filed a Form 144 with = the SEC on Dec. 6 to sell $52 million worth of ImClone stock. Wall Street= is afraid earnings and accounting scandals will dominate financial news fo= r some time to come. Arthur Andersen generated $50 million in accounting fe= es from Enron last year, and companies like Enron have a lot of muscle with= their auditors. In order to win the business, the consulting arm comes up = with the tax avoidance scheme and earnings enhancement method, and the audi= ting division implements the strategy. Like a weight lifter taking stero= ids, large cap companies are addicted to beefing up their financial perform= ance at any cost. And just like the weightlifter taking steroids, this perf= ormance enhancement is not only toxic long term, it is also illegal. In t= he small and micro cap arena there is significant risk associated with fail= ed corporate performance. However, these smaller companies do not have the = fiscal muscle to make their auditors bend the rules to enhance financial pe= rformance. You won't see many small company scandals associated with accoun= ting irregularities. Their auditors take a much more conservative approach,= as the auditor is more concerned with covering his own butt than collectin= g the reduced fees. During this past week, while Wall Street was annihila= ting several of its large cap favorites, Cross Media (AMEX: XMM) and Energy= Power (OTC BB: EYPSF) both traded up. Small stocks still remain a preferre= d and level playing field for individual investors. Charts Provided Cour= tesy Of TradePortal.com The OTC Journal is a proud partner of the SwingW= ire.com Online Investment Community . A next generation Online Analyst Exch= ange providing Members the ability to search, review, track and monitor som= e of the Internet's best Online CAs (CyberAnalysts). Members have the oppor= tunity to potentially achieve higher returns by viewing top performing port= folios and receiving real-time alerts from favorite CAs. SwingWire.com = also has a lucrative incentive model for experienced investors and traders = who consistently outperform the market. Share market ideas with other like-= minded investors, establish a proven track record, provide insightful comme= ntary, attract followers and ultimately become one of the Internet's highes= t paid and most sought after CyberAnalysts! Click here to receive your F= REE 30-Day Trial Membership with no further obligation. Sign Up Today! = Disclaimer The OTCjournal.com Newsletter is an independent electronic = publication committed to providing our readers with factual information on = selected publicly traded companies. All companies are chosen on the basis = of certain financial analysis and other pertinent criteria with a view towa= rd maximizing the upside potential for investors while minimizing the down= side risk, whenever possible. Moreover, as detailed below, this publicatio= n accepts compensation from certain of the companies which it features. Li= kewise, this newsletter is owned by MarketByte, LLC. To the degrees enumer= ated herein, this newsletter should not be regarded as an independent publ= ication. Click Here to view our compensation on every company we have ev= er covered, or visit the following web address: http://www.otcjournal.com/= disclaimer.html for our full profiles and http://www.otcjournal.com/tradin= g-alerts/disclaimer.html for Trading Alerts. All statements and expressi= ons are the sole opinions of the editors and are subject to change without= notice. A profile, description, or other mention of a company in the newsl= etter is neither an offer nor solicitation to buy or sell any securities m= entioned. While we believe all sources of information to be factual and rel= iable, in no way do we represent or guarantee the accuracy thereof, nor the= statements made herein. The editor, members of the editor's family, and/= or entities with which they are affiliated, are forbidden by company policy= to own, buy, sell or otherwise trade stock for their own benefit in the co= mpanies who appear in the publication unless specifically disclosed in the = newsletter. The profiles, critiques, and other editorial content of the O= TCjournal.com may contain forward-looking statements relating to the expect= ed capabilities of the companies mentioned herein. THE READER SHOULD VERI= FY ALL CLAIMS AND DO THEIR OWN DUE DILIGENCE BEFORE INVESTING IN ANY SECURI= TIES MENTIONED. INVESTING IN SECURITIES IS SPECULATIVE AND CARRIES A HIGH = DEGREE OF RISK. THE INFORMATION FOUND IN THIS PROFILE IS PROTECTED BY THE C= OPYRIGHT LAWS OF THE UNITED STATES AND MAY NOT BE COPIED, OR REPRODUCED IN = ANY WAY WITHOUT THE EXPRESSED, WRITTEN CONSENT OF THE EDITORS OF OTCjourna= l.com. We encourage our readers to invest carefully and read the investor= information available at the web sites of the Securities and Exchange Com= mission ("SEC") at http://www.sec.gov and/or the National Association of Se= curities Dealers ("NASD") at http://www.nasd.com . We also strongly recomme= nd that you read the SEC advisory to investors concerning Internet Stock Fr= aud, which can be found at http://www.sec.gov/consumer/cyberfr.htm . Reade= rs can review all public filings by companies at the SEC's EDGAR page. The = NASD has published information on how to invest carefully at its web site. = Unsubscribe Here You can unsubscribe from this list at any time by = Clicking Here and HITTING SEND. If you are having difficulty removing your= self or wish to change your address please go to http://listserv.otcjournal= .com/opt.cgi?email=3DMIKE.CARSON@ENRON.COM . =09 [IMAGE]=09=09 [IMAGE]=09=09 [IMAGE]=09=09 [IMAGE]=09=09 [IMAGE]=09=09 [IMAGE]=09=09 [IMAGE]=09=09 [IMAGE]=09=09 [IMAGE]=09[IMAGE]=09 =20 --- You are currently subscribed to otcjournal as: MIKE.CARSON@ENRON.COM To unsubscribe send a blank email to leave-otcjournal-1011326V@lyris.otcjou= rnal.com
|